![InnovateUK_LogoA_Interim_RGBx320govuk[1]](http://blogs.bournemouth.ac.uk/research/files/2014/12/InnovateUK_LogoA_Interim_RGBx320govuk11-300x90.jpg)
Projects need to focus on identified technical or commercial challenges. Innovate UK will fund projects that aim to lead to increased UK SME productivity, competitiveness and growth.
Projects need to be led by a business and must involve at least one SME. They can be carried out by an SME working alone or in collaboration with other organisations. Projects with costs of £100,000 or more must involve working with other partners
Innovate UK are looking for projects which focus on any of the technical feasibility, industrial research or experimental development research categories.
Projects should last between 6 months and 3 years. They should range from total costs of £50,000 to £2 million.
If you are interested in submitting to any of the above calls you must contact your RKEO Funding Development Officer with adequate notice before the deadline.
For more funding opportunities that are most relevant to you, you can set up your own personalised alerts on Research Professional. If you need help setting these up, just ask your School’s/Faculty’s Funding Development Officer in RKEO or view the recent blog post here.
If thinking of applying, why not add notification of your interest on Research Professional’s record of the bid so that BU colleagues can see your intention to bid and contact you to collaborate.
Innovate UK announce Digital Technology for Healthcare call










BU PhD student attending HIV conference on scholarship
ESRC SWDTP – Applications open for PhD Studentships for September 2026
New paper by CMWH PhD student
Further CMWH contributions to 2026 ICM congress
ECR Funding Open Call: Research Culture & Community Grant – Apply Now
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Horizon Europe 2025 Work Programme pre-Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease